Investors
Enterprise grade, here to stay
Every line below is quoted from HydRegen's own website, with its source. Nothing is estimated.
Background: illustrative render, not a real site or product.
Every line below is quoted from HydRegen's own website, with its source. Nothing is estimated.
Background: illustrative render, not a real site or product.
Cleaner, safer, more efficient chemical manufacture. A spinout from the University of Oxford, commercialising a novel biotechnology. Our ‘slot in’ technologies allow you to replace your heavy metal catalyst for hydrogenation reactions, or decarbonise existing redox biocatalysis processes all whilst operating within existing flow hydrogenation reactors.
From HydRegen's home page meta description and copy.
“HydRegen is led by an experienced, multidisciplinary team spanning science, scale-up, operations and commercialisation. Together, we have the expertise to take HydRegen’s biotech platforms from breakthrough technology to successful industrial adoption.”
“➡ 3 x CO2 savings compared to traditional metal catalysed hydrogenations ➡ benchmarking for paracetamol production ➡ clean and efficient chemistry ➡ >£2.6m clean tech funding ➡ supported by University of Oxford , Oxford University Innovation and Prof Kylie Vincent”
“HydRegen, the revolutionary bioscience company, is excited to announce the appointment of Matthew Hodges as Commercial and Operations Lead, directing the commercial strategy and assisting in the development of its lead product. Matt brings a strong background in building businesses for fundraising, winning public grant applications and creating successful partnerships in both commercial and scientific areas.”
“🚀 We are now looking to raise £8m, focusing on accelerating our growth, increasing joint-development capabilities and therefore fast-tracking licensing and revenue generation via commercial manufacturing.”
“We were delighted to win a place on the UK trade mission to San Francisco, led by Innovate UK Business Growth, which centered on attending SynBioBeta. This was an excellent opportunity to meet other leading UK companies in the sector as well as US-based partners and investors.”
“HydRegen, the Oxford-based biotechnology company enabling sustainable chemical manufacturing, has secured a £2.6 million investment as part of its latest fundraise, led by Clean Growth Fund , the UK clean-tech venture capital fund.”
“In March 2022, the company received £385,000 in funding from the UK Innovation & Science Seed Fund (UKI2S), alongside private investors, to work in collaboration with pharmaceutical and fine chemical companies wanting to reduce their costs and environmental impact.”
“Conference Participation : Invited to speak at numerous technical conferences and presented posters and flash talks.”
“Not only does this make it easier for us to scale, but it makes our technology transfer to partners and customers faster.”
Source: https://hydregenoxford.com
“We have a variety of commercial frameworks to meet end-user needs, recognizing different requirements at different stages of chemical manufacturing, from hit identification, through to scale up.”
Source: https://hydregenoxford.com
“In his new role, Pierre will work across HydRegen’s chemistry and engineering teams to help de-risk the company’s lead processes and advance them towards its manufacturing goals. His work will support the translation of strong laboratory results into robust and commercially relevant processes.”
Source: https://hydregenoxford.com/news
“As we work at increasingly higher Technology Readiness Levels (TRL 7+), we welcome Bethan and Stephen – whose combined experience bridges biocatalysis, continuous flow, process scale-up and industrial innovation to reduce our time to tech transfer and pilot scale manufacturing, accelerating commercial partnership timelines from 6-12 months to as little as 3-6 months.”
Source: https://hydregenoxford.com/news
“As the chemical manufacturing industry faces the dual pressures of sustainability and rising cost competition, it’s clear that next-generation technologies cannot rely on a “green premium” to succeed. While these emerging solutions offer significant benefits including reducing environmental impact, improving safety and fostering market growth, the challenges of implementation and cost must be carefully considered.”
Source: https://hydregenoxford.com/news
“Decarbonise biocatalysis: We believe that improving implementation of redox biocatalysis will ultimately speed up a switch to bio-based feedstocks, building circular and bio-based economies.”
In his new role, Pierre will work across HydRegen’s chemistry and engineering teams to help de-risk the company’s lead processes and advance them towa
➡ 3 x CO2 savings compared to traditional metal catalysed hydrogenations ➡ benchmarking for paracetamol production ➡ clean and efficient chemistry ➡ >
We asked Jack to introduce himself and tell us about why he chose to study Chemistry, what brought him to HydRegen and what he’s learnt in his first m
HydRegen, the revolutionary bioscience company, is excited to announce the appointment of Matthew Hodges as Commercial and Operations Lead, directing
HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of Joe de Sousa as Non-Executive Director. With a background in
HydRegen, the revolutionary bioscience company, have appointed Miguel Ramirez Hernandez as Head of Molecular Biology and Enzyme Production. Miguel wil
Every good start-up relies on high-quality resources, and it can’t be underestimated how first-rate equipment is aiding our research and development a
Huddersfield, United Kingdom - 11 June 2025 James Robinson Speciality Ingredients (JRSI) and HydRegen today announced a strategic collaboration to imp
🌱 HydRegen is a biotech company delivering cleaner, safer and more economical chemical manufacturing strategies.
HydRegen, the revolutionary bioscience company, completes first scale up demonstration of the joint HydRegen-Almac Sciences bio-manufacturing route to
Revolutionary Oxford biotechnology company pursues a huge growth opportunity to decarbonise the global chemical manufacturing and pharmaceutical indus
As we wrap up another year of groundbreaking research and development, we are thrilled to share the remarkable achievements of our Chemistry Team. Thi
We couldn't find the page you were looking for. This is either because:
We are proud to initiate two groundbreaking joint development projects targeting the sustainable production of widely used consumer products. These co
The pharmaceuticals landscape is changing, in a positive way, and there is a growing appetite from both business and regulators for new technology and
An invitation by ThalesNano to give a webinar was too good an opportunity to miss! Ever since we started thinking about working in continuous flow (ba
The HydRegen technology is grounded in 10 years of academic research and formally spanout of the Department of Chemistry, University of Oxford in Marc
We are delighted to have been highlighted as a Case Study by Advanced Oxford as part of the 'Green Recovery’ series.
Following their attendance at the recent NextGenBiocat symposium, HydRegen’s Chief Scientific Officer, Sarah Cleary, and Product Development Specialis
HydRegen’s industrial biotechnology platforms deliver sustainable, safe and cost-efficient chemical processes. Partnerships with major chemicals compa
HydRegen is passionate about finding and supporting both new and developed scientists who are committed to reducing the environmental impact of chemic
The chemicals sector is critical to nearly all manufacturing industries, converting raw materials like oil, natural gas, and minerals into essential c
Hydrogenation, a fundamental chemical process with broad applications across petrochemicals, pharmaceuticals, and food production has traditionally re
At the core of HydRegen's mission to make chemical manufacturing safer and more sustainable lies a team of exceptional scientists dedicated to pushing
Crucial to the global economy, the chemical industry underpins sectors from pharmaceuticals, agriculture to consumer goods and has one of the most com
As catastrophic climatic events become increasingly common and the world races toward the 1.5°C threshold outlined in the Paris Agreement, global indu
Reproduced from: Biocatalytic Nitro Hydrogenations team , Royal Society of Chemistry
Originally posted: University of Oxford Spin-Out Named Winner of ‘Golden Ticket’ Programme for Planetary Health Innovations - Pioneer Group (thepionee
Following the introduction of Yinqi and her expertise in biocatalysis, we now turn to synthetic organic chemist, Becky .
In today's competitive job market, early-stage undergraduates often gravitate toward established corporate giants, drawn in by their prestigious names
HydRegen , the revolutionary bioscience company, is pleased to announce the appointment of John Boyle as a Scientist of Organic Chemistry. With more t
HydRegen, the revolutionary bioscience company, is proud to announce the appointment of Giovanni Davide Barone as Molecular Biology Specialist, to exp
With over two decades of leadership in the global chemical industry, Kevin combines a deep understanding of the sector with proven experience in scali
Oxford, UK – HydRegen is pleased to announce the appointment of Kat Usachova as Analytical and DSP Chemist, further strengthening the company's capabi
From the outset of our partnership with HydRegen in June 2023, we have witnessed exceptional progress across all fronts, aligning with the leadership
HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of Piera De Santis as a Scientist of Molecular Biology. Followi
HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of Dr Willem Breukelaar as a Scientist and specialist in biocat
Oxford, UK – HydRegen is pleased to welcome Mark Eldridge to the team as Synthetic Biologist, strengthening the company’s biological capabilities as i
HydRegen is pleased to welcome Pierre Moreau to the team as Process Engineer, Chemistry , strengthening the company’s process development and scale-up
The future of industrial catalysis lies in bio-based solutions, and the time to invest in that future is now.
In recent decades, globalisation enabled the chemical manufacturing industry to outsource production to regions with lower labour costs, abundant raw